Growth Metrics

BioNexus Gene Lab (BGLC) Cash from Financing Activities (2018 - 2026)

BioNexus Gene Lab recorded quarterly Cash from Financing Activities of $59709.0 in Q1 2026, down 77.6% quarter-over-quarter from $266544.0 in Q4 2025, and up 7042.91% year-over-year from $835.92 in Q1 2025.

BioNexus Gene Lab's Cash from Financing Activities history runs 9 years deep, the most recent figure standing at $59709.0 for Q1 2026.

  • In Q1 2026, Cash from Financing Activities rose 7042.91% year-over-year to $59709.0; the TTM figure through Mar 2026 stood at $359410.0 (up 1609.17% YoY), while the FY2025 annual figure was $298841.0, up 7418.01% from the prior year.
  • Cash from Financing Activities came in at $59709.0 for Q1 2026 at BioNexus Gene Lab, down from $266544.0 in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $5.7 million in Q3 2023 to a low of -$142387.0 in Q4 2024.
  • A 5-year average of $421602.0 and a median of $13035.0 in 2024 frame the typical range for Cash from Financing Activities.
  • Across the five-year window, Cash from Financing Activities surged 331172.47% in 2023 and sank 126.78% in 2024, its largest moves.
  • BioNexus Gene Lab's Cash from Financing Activities stood at -$2273.0 in 2022, then soared by 23493.44% to $531733.0 in 2023, then tumbled by 126.78% to -$142387.0 in 2024, then surged by 287.2% to $266544.0 in 2025, then plunged by 77.6% to $59709.0 in 2026.
  • According to Business Quant data, Cash from Financing Activities over the past three periods registered $59709.0, $266544.0, and $34187.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Linde 230.79 Bn 226.84 Bn 4.26 Bn -1.97 Bn
2 Chemical & Mining Co Of Chile 127.66 Bn 124.93 Bn 778.60 Mn -
3 Sherwin Williams 72.51 Bn 72.30 Bn 2.78 Bn 47.60 Mn
4 Ecolab 70.96 Bn 70.34 Bn 1.85 Bn -431.60 Mn
5 Air Products & Chemicals 62.15 Bn 63.70 Bn 987.40 Mn -101.00 Mn
6 Ppg Industries 25.04 Bn 23.57 Bn 1.66 Bn -334.00 Mn
7 LyondellBasell Industries 21.62 Bn 21.73 Bn 701.00 Mn -236.00 Mn
8 Albemarle 20.26 Bn 19.42 Bn 500.97 Mn -1.41 Bn
9 DuPont de Nemours 19.45 Bn 19.56 Bn 602.00 Mn -44.00 Mn
10 BioNexus Gene Lab 5.34 Mn 1.38 Mn -790.00 59,709.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 59,709.00
Mar 31, 2026 59,709.00
Dec 31, 2025 266,544.00
Dec 31, 2025 266,544.00
Sep 30, 2025 34,187.00
Sep 30, 2025 34,187.00
Jun 30, 2025 -1,030.00
Jun 30, 2025 -1,030.00
Mar 31, 2025 -860.00
Mar 31, 2025 -860.00
Dec 31, 2024 -142,387.00
Dec 31, 2024 -142,387.00
Sep 30, 2024 -55,982.00
Sep 30, 2024 -55,982.00
Jun 30, 2024 175,414.00
Jun 30, 2024 175,414.00
Mar 31, 2024 26,930.00
Mar 31, 2024 26,930.00
Dec 31, 2023 531,733.00
Dec 31, 2023 531,733.00
Sep 30, 2023 5.75 Mn
Sep 30, 2023 5.75 Mn
Jun 30, 2023 -2,433.00
Jun 30, 2023 -2,433.00
Mar 31, 2023 -1,779.00
Mar 31, 2023 -1,779.00
Dec 31, 2022 -2,273.00
Dec 31, 2022 -2,273.00
Sep 30, 2022 -1,736.00
Sep 30, 2022 -1,736.00
Jun 30, 2022 112,177.00
Jun 30, 2022 112,177.00
Dec 31, 2021 -4,959.00
Dec 31, 2021 -4,959.00
Sep 30, 2021 -6,081.00
Sep 30, 2021 -6,081.00
Jun 30, 2021 -8,632.00
Jun 30, 2021 -8,632.00
Mar 31, 2021 -8,550.00
Mar 31, 2021 -8,550.00
Dec 31, 2020 2,256.00
Dec 31, 2020 2,256.00
Sep 30, 2020 2,186.00
Sep 30, 2020 2,186.00
Jun 30, 2020 -2,990.00
Jun 30, 2020 -2,990.00
Mar 31, 2020 -6,399.00
Mar 31, 2020 -6,399.00
Dec 31, 2019 -73,472.00
Dec 31, 2019 -73,472.00
Sep 30, 2019 -98,632.00
Sep 30, 2019 -98,632.00
Jun 30, 2019 -5,095.00
Jun 30, 2019 -5,095.00
Mar 31, 2019 -3,606.00
Mar 31, 2019 -3,606.00
Dec 31, 2018 -427,857.00
Dec 31, 2018 -427,857.00
Mar 31, 2018 1.12 Mn
Mar 31, 2018 1.12 Mn